Report Detail
Global mRNA Synthesis Service Market Growth (Status and Outlook) 2022-2028
- RnM4461922 |
- 04 July, 2022 |
- Global |
- 122 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of mRNA Synthesis Service will have significant change from previous year. According to our (LP Information) latest study, the global mRNA Synthesis Service market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global mRNA Synthesis Service market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States mRNA Synthesis Service market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global mRNA Synthesis Service market, reaching US$ million by the year 2028. As for the Europe mRNA Synthesis Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main mRNA Synthesis Service players cover APExBIO, Takeda Pharmaceuticals, Tesla, and Thermo Fisher Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
mRNA Vaccine Synthesis
mRNA Drug Synthesis
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Clinical
Research
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
APExBIO
Takeda Pharmaceuticals
Tesla
Thermo Fisher Scientific
VGXI
WACKER Chemie
Siegfried
ST Pharm
Novartis
Novo Nordisk
Pfizer
LakePharma
Lion TCR
Lonza
Merck
GlaxoSmithKline
GenePharma
Fareva
Fosun Pharma
GC Pharma
Syneos Health
Bayer
Beijing Tricision Biotherapeutics
Cellerna
Eli Lilly
CMC Pharmaceuticals
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global mRNA Synthesis Service Market Size 2017-2028
- 2.1.2 mRNA Synthesis Service Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 mRNA Synthesis Service Segment by Type
- 2.2.1 mRNA Vaccine Synthesis
- 2.2.2 mRNA Drug Synthesis
- 2.3 mRNA Synthesis Service Market Size by Type
- 2.3.1 mRNA Synthesis Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global mRNA Synthesis Service Market Size Market Share by Type (2017-2022)
- 2.4 mRNA Synthesis Service Segment by Application
- 2.4.1 Clinical
- 2.4.2 Research
- 2.4.3 Others
- 2.5 mRNA Synthesis Service Market Size by Application
- 2.5.1 mRNA Synthesis Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global mRNA Synthesis Service Market Size Market Share by Application (2017-2022)
3 mRNA Synthesis Service Market Size by Player
- 3.1 mRNA Synthesis Service Market Size Market Share by Players
- 3.1.1 Global mRNA Synthesis Service Revenue by Players (2020-2022)
- 3.1.2 Global mRNA Synthesis Service Revenue Market Share by Players (2020-2022)
- 3.2 Global mRNA Synthesis Service Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 mRNA Synthesis Service by Regions
- 4.1 mRNA Synthesis Service Market Size by Regions (2017-2022)
- 4.2 Americas mRNA Synthesis Service Market Size Growth (2017-2022)
- 4.3 APAC mRNA Synthesis Service Market Size Growth (2017-2022)
- 4.4 Europe mRNA Synthesis Service Market Size Growth (2017-2022)
- 4.5 Middle East & Africa mRNA Synthesis Service Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas mRNA Synthesis Service Market Size by Country (2017-2022)
- 5.2 Americas mRNA Synthesis Service Market Size by Type (2017-2022)
- 5.3 Americas mRNA Synthesis Service Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC mRNA Synthesis Service Market Size by Region (2017-2022)
- 6.2 APAC mRNA Synthesis Service Market Size by Type (2017-2022)
- 6.3 APAC mRNA Synthesis Service Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe mRNA Synthesis Service by Country (2017-2022)
- 7.2 Europe mRNA Synthesis Service Market Size by Type (2017-2022)
- 7.3 Europe mRNA Synthesis Service Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa mRNA Synthesis Service by Region (2017-2022)
- 8.2 Middle East & Africa mRNA Synthesis Service Market Size by Type (2017-2022)
- 8.3 Middle East & Africa mRNA Synthesis Service Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global mRNA Synthesis Service Market Forecast
- 10.1 Global mRNA Synthesis Service Forecast by Regions (2023-2028)
- 10.1.1 Global mRNA Synthesis Service Forecast by Regions (2023-2028)
- 10.1.2 Americas mRNA Synthesis Service Forecast
- 10.1.3 APAC mRNA Synthesis Service Forecast
- 10.1.4 Europe mRNA Synthesis Service Forecast
- 10.1.5 Middle East & Africa mRNA Synthesis Service Forecast
- 10.2 Americas mRNA Synthesis Service Forecast by Country (2023-2028)
- 10.2.1 United States mRNA Synthesis Service Market Forecast
- 10.2.2 Canada mRNA Synthesis Service Market Forecast
- 10.2.3 Mexico mRNA Synthesis Service Market Forecast
- 10.2.4 Brazil mRNA Synthesis Service Market Forecast
- 10.3 APAC mRNA Synthesis Service Forecast by Region (2023-2028)
- 10.3.1 China mRNA Synthesis Service Market Forecast
- 10.3.2 Japan mRNA Synthesis Service Market Forecast
- 10.3.3 Korea mRNA Synthesis Service Market Forecast
- 10.3.4 Southeast Asia mRNA Synthesis Service Market Forecast
- 10.3.5 India mRNA Synthesis Service Market Forecast
- 10.3.6 Australia mRNA Synthesis Service Market Forecast
- 10.4 Europe mRNA Synthesis Service Forecast by Country (2023-2028)
- 10.4.1 Germany mRNA Synthesis Service Market Forecast
- 10.4.2 France mRNA Synthesis Service Market Forecast
- 10.4.3 UK mRNA Synthesis Service Market Forecast
- 10.4.4 Italy mRNA Synthesis Service Market Forecast
- 10.4.5 Russia mRNA Synthesis Service Market Forecast
- 10.5 Middle East & Africa mRNA Synthesis Service Forecast by Region (2023-2028)
- 10.5.1 Egypt mRNA Synthesis Service Market Forecast
- 10.5.2 South Africa mRNA Synthesis Service Market Forecast
- 10.5.3 Israel mRNA Synthesis Service Market Forecast
- 10.5.4 Turkey mRNA Synthesis Service Market Forecast
- 10.5.5 GCC Countries mRNA Synthesis Service Market Forecast
- 10.6 Global mRNA Synthesis Service Forecast by Type (2023-2028)
- 10.7 Global mRNA Synthesis Service Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 APExBIO
- 11.1.1 APExBIO Company Information
- 11.1.2 APExBIO mRNA Synthesis Service Product Offered
- 11.1.3 APExBIO mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 APExBIO Main Business Overview
- 11.1.5 APExBIO Latest Developments
- 11.2 Takeda Pharmaceuticals
- 11.2.1 Takeda Pharmaceuticals Company Information
- 11.2.2 Takeda Pharmaceuticals mRNA Synthesis Service Product Offered
- 11.2.3 Takeda Pharmaceuticals mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Takeda Pharmaceuticals Main Business Overview
- 11.2.5 Takeda Pharmaceuticals Latest Developments
- 11.3 Tesla
- 11.3.1 Tesla Company Information
- 11.3.2 Tesla mRNA Synthesis Service Product Offered
- 11.3.3 Tesla mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Tesla Main Business Overview
- 11.3.5 Tesla Latest Developments
- 11.4 Thermo Fisher Scientific
- 11.4.1 Thermo Fisher Scientific Company Information
- 11.4.2 Thermo Fisher Scientific mRNA Synthesis Service Product Offered
- 11.4.3 Thermo Fisher Scientific mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Thermo Fisher Scientific Main Business Overview
- 11.4.5 Thermo Fisher Scientific Latest Developments
- 11.5 VGXI
- 11.5.1 VGXI Company Information
- 11.5.2 VGXI mRNA Synthesis Service Product Offered
- 11.5.3 VGXI mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 VGXI Main Business Overview
- 11.5.5 VGXI Latest Developments
- 11.6 WACKER Chemie
- 11.6.1 WACKER Chemie Company Information
- 11.6.2 WACKER Chemie mRNA Synthesis Service Product Offered
- 11.6.3 WACKER Chemie mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 WACKER Chemie Main Business Overview
- 11.6.5 WACKER Chemie Latest Developments
- 11.7 Siegfried
- 11.7.1 Siegfried Company Information
- 11.7.2 Siegfried mRNA Synthesis Service Product Offered
- 11.7.3 Siegfried mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Siegfried Main Business Overview
- 11.7.5 Siegfried Latest Developments
- 11.8 ST Pharm
- 11.8.1 ST Pharm Company Information
- 11.8.2 ST Pharm mRNA Synthesis Service Product Offered
- 11.8.3 ST Pharm mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 ST Pharm Main Business Overview
- 11.8.5 ST Pharm Latest Developments
- 11.9 Novartis
- 11.9.1 Novartis Company Information
- 11.9.2 Novartis mRNA Synthesis Service Product Offered
- 11.9.3 Novartis mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Novartis Main Business Overview
- 11.9.5 Novartis Latest Developments
- 11.10 Novo Nordisk
- 11.10.1 Novo Nordisk Company Information
- 11.10.2 Novo Nordisk mRNA Synthesis Service Product Offered
- 11.10.3 Novo Nordisk mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Novo Nordisk Main Business Overview
- 11.10.5 Novo Nordisk Latest Developments
- 11.11 Pfizer
- 11.11.1 Pfizer Company Information
- 11.11.2 Pfizer mRNA Synthesis Service Product Offered
- 11.11.3 Pfizer mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Pfizer Main Business Overview
- 11.11.5 Pfizer Latest Developments
- 11.12 LakePharma
- 11.12.1 LakePharma Company Information
- 11.12.2 LakePharma mRNA Synthesis Service Product Offered
- 11.12.3 LakePharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 LakePharma Main Business Overview
- 11.12.5 LakePharma Latest Developments
- 11.13 Lion TCR
- 11.13.1 Lion TCR Company Information
- 11.13.2 Lion TCR mRNA Synthesis Service Product Offered
- 11.13.3 Lion TCR mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Lion TCR Main Business Overview
- 11.13.5 Lion TCR Latest Developments
- 11.14 Lonza
- 11.14.1 Lonza Company Information
- 11.14.2 Lonza mRNA Synthesis Service Product Offered
- 11.14.3 Lonza mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Lonza Main Business Overview
- 11.14.5 Lonza Latest Developments
- 11.15 Merck
- 11.15.1 Merck Company Information
- 11.15.2 Merck mRNA Synthesis Service Product Offered
- 11.15.3 Merck mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Merck Main Business Overview
- 11.15.5 Merck Latest Developments
- 11.16 GlaxoSmithKline
- 11.16.1 GlaxoSmithKline Company Information
- 11.16.2 GlaxoSmithKline mRNA Synthesis Service Product Offered
- 11.16.3 GlaxoSmithKline mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 GlaxoSmithKline Main Business Overview
- 11.16.5 GlaxoSmithKline Latest Developments
- 11.17 GenePharma
- 11.17.1 GenePharma Company Information
- 11.17.2 GenePharma mRNA Synthesis Service Product Offered
- 11.17.3 GenePharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 GenePharma Main Business Overview
- 11.17.5 GenePharma Latest Developments
- 11.18 Fareva
- 11.18.1 Fareva Company Information
- 11.18.2 Fareva mRNA Synthesis Service Product Offered
- 11.18.3 Fareva mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Fareva Main Business Overview
- 11.18.5 Fareva Latest Developments
- 11.19 Fosun Pharma
- 11.19.1 Fosun Pharma Company Information
- 11.19.2 Fosun Pharma mRNA Synthesis Service Product Offered
- 11.19.3 Fosun Pharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 Fosun Pharma Main Business Overview
- 11.19.5 Fosun Pharma Latest Developments
- 11.20 GC Pharma
- 11.20.1 GC Pharma Company Information
- 11.20.2 GC Pharma mRNA Synthesis Service Product Offered
- 11.20.3 GC Pharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 GC Pharma Main Business Overview
- 11.20.5 GC Pharma Latest Developments
- 11.21 Syneos Health
- 11.21.1 Syneos Health Company Information
- 11.21.2 Syneos Health mRNA Synthesis Service Product Offered
- 11.21.3 Syneos Health mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.21.4 Syneos Health Main Business Overview
- 11.21.5 Syneos Health Latest Developments
- 11.22 Bayer
- 11.22.1 Bayer Company Information
- 11.22.2 Bayer mRNA Synthesis Service Product Offered
- 11.22.3 Bayer mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.22.4 Bayer Main Business Overview
- 11.22.5 Bayer Latest Developments
- 11.23 Beijing Tricision Biotherapeutics
- 11.23.1 Beijing Tricision Biotherapeutics Company Information
- 11.23.2 Beijing Tricision Biotherapeutics mRNA Synthesis Service Product Offered
- 11.23.3 Beijing Tricision Biotherapeutics mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.23.4 Beijing Tricision Biotherapeutics Main Business Overview
- 11.23.5 Beijing Tricision Biotherapeutics Latest Developments
- 11.24 Cellerna
- 11.24.1 Cellerna Company Information
- 11.24.2 Cellerna mRNA Synthesis Service Product Offered
- 11.24.3 Cellerna mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.24.4 Cellerna Main Business Overview
- 11.24.5 Cellerna Latest Developments
- 11.25 Eli Lilly
- 11.25.1 Eli Lilly Company Information
- 11.25.2 Eli Lilly mRNA Synthesis Service Product Offered
- 11.25.3 Eli Lilly mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.25.4 Eli Lilly Main Business Overview
- 11.25.5 Eli Lilly Latest Developments
- 11.26 CMC Pharmaceuticals
- 11.26.1 CMC Pharmaceuticals Company Information
- 11.26.2 CMC Pharmaceuticals mRNA Synthesis Service Product Offered
- 11.26.3 CMC Pharmaceuticals mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2022)
- 11.26.4 CMC Pharmaceuticals Main Business Overview
- 11.26.5 CMC Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on mRNA Synthesis Service. Industry analysis & Market Report on mRNA Synthesis Service is a syndicated market report, published as Global mRNA Synthesis Service Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of mRNA Synthesis Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
